OrthoPediatrics Corp. (KIDS) Analysts See $-0.13 EPS

July 14, 2018 - By Christine McCrea

Analysts expect OrthoPediatrics Corp. (NASDAQ:KIDS) to report $-0.13 EPS on August, 13.After having $-0.41 EPS previously, OrthoPediatrics Corp.’s analysts see -68.29 % EPS growth. It closed at $29.37 lastly. It is down 0.00% since July 14, 2017 and is . It has underperformed by 12.57% the S&P500.

OrthoPediatrics Corp. designs, develops, and sells orthopedic implants for children. The company has market cap of $375.12 million. It offers trauma and deformity correction products, including cannulated screws; The Locking Cannulated Blade plate system that offers various treatment options for pediatric hip deformity, fixed knee flexion deformity, and trauma; The Locking Proximal Femur plate system for long bone fractures and osteotomies in children and adolescents; flexible nailing systems; The OP PediFrag System, a fragment set for pediatric orthopedic surgery; The PediLoc Extension Osteotomy plates; locking plated systems for the treatment of pediatric femur fractures and osteotomies; intramedullary nails; plate systems that provide physeal tethering techniques; and an engineered device for casting procedures. It currently has negative earnings. The firm also offers spine and sports medicine systems, and clinical education.

More important recent OrthoPediatrics Corp. (NASDAQ:KIDS) news were published by: Globenewswire.com which released: “OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan” on June 18, 2018, also Orthospinenews.com published article titled: “OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery”, Streetinsider.com published: “OrthoPediatrics Corp. (KIDS) PT Raised to $30 at Piper Jaffray Following Investor Meetings” on July 05, 2018. More interesting news about OrthoPediatrics Corp. (NASDAQ:KIDS) was released by: Globenewswire.com and their article: “OrthoPediatrics Corp. Announces Full Launch of Pediatric Nailing Platform | FEMUR” with publication date: July 11, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: